LB
About
Leaps is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, we aim to shift key paradigms in life science, changing the world for better. In health, we pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, we drive innovations that could nourish a growing population while restoring the planet. It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 4 investors are based in Leverkusen, Nordrhein-Westfalen, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Stages
- series-a
- Sectors
- biotech
- Location
- Leverkusen, Germany
Contact Information
Find more investors like Leaps
Search Investors